Guidance of EFSA on risk assessments for active substances of plant protection products that have stereoisomers as components or impurities and for transformation products of active substances that may have stereoisomers

欧洲食品安全局 (EFSA) 关于植物保护产品活性物质(其成分或杂质为立体异构体)以及活性物质转化产物(可能含有立体异构体)风险评估的指南

阅读:2

Abstract

In response to the request of the European Commission to EFSA, this document provides guidance on the information necessary to perform the risk assessment of plant protection active substances that contain stereoisomers in their composition as active components or impurities. The guidance should also be used for active substances that without containing any stereogenic element may generate transformation products or metabolites that do contain them. As a general principle, stereoisomers need to be treated as different chemical components for the risk assessment. Current data requirements in the EU regulatory framework (Regulation (EC) No 1107/2009 and Regulation (EC) No 396/2005) already establish that the substance tested should match the technical specifications (including its isomeric composition) and that formation and effects of metabolites, degradation and transformation products should be investigated (which certainly includes the case when transformation products are stereoisomers). Experience gained during the application of EU pesticides regulation has shown that guidance may be needed to provide applicants and evaluators advice on how to generate and assess the required data. Also, guidance is needed on how to make the best use of the available information to perform the risk assessment of these substances, particularly in situations when the information on individual isomers is not available or difficult to obtain, with a primary objective being to reduce the need for repeating vertebrate animal testing. This guidance does not aim to provide specific technical advice on analytical methods. In this guidance, the Regulation (EU) 283/2013 on the data requirements for the plant protection active substances is analysed and recommendations are given on how to best address and assess data requirements for active substances containing stereoisomers.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。